Therefore, in obesity-related CRC, hyperinsulinemia and hyperglycemia may be involved in the decreased expression of TET2 by an AMPK-mediated mechanism. The gene discussed is TET2; the disease is obesity due to melanocortin 4 receptor deficiency.